Influence of Streptozotocin-induced Diabetes on New Bone Formation by rhBMP-2

Abstract

We studied bone formation induced by recombinant human bone morphogenetic protein-2 (rhBMP-2) combined with polylactate-polyglycolate-copolymer/gelatine sponge complexes (PGS) at palatal subperiosteal sites in 54 male Wister rats with STZ-induced diabetes mellitus (DM), insulin-treated STZ-induced diabetes mellitus (INS-DM), or nondiabetes mellitus (nonDM). Rats were divided into 6 groups consisting of PGS implanted alone (nonDM-PGS, DM-PGS, and INS-DM-PGS) and rhBMP-2 combined with PGS implanted (nonDM-BMP, DM-BMP, and INS-DM-BMP). Rats were sacrificed 6 weeks after implantation and histopathologically observaed and histometrically evaluated. New bone formation was observed in all groups, and the new bone was almost completely continuous with the original palatal bone. The DM-PGS group showed significantly less new bone thickness among the 3 groups with PGS implantion alone. NonDM-BMP, DM-BMP and INS-DM-BMP showed significantly greater new bone thickness than did nonDM-PGS, DM-PGS, and INS-DM-PGS groups.
These results indicate that rhBMP-2 combined with PGS enhances new bone formation continuous with original bone under STZ-induced diabetes status, although it decreases reparative bone formation.